<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK253404" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK253404/" /><meta name="ncbi_pagename" content="Arterial Tortuosity Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Arterial Tortuosity Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Arterial Tortuosity Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/11/13" /><meta name="citation_author" content="Bert Callewaert" /><meta name="citation_author" content="Anne De Paepe" /><meta name="citation_author" content="Paul Coucke" /><meta name="citation_pmid" content="25392904" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK253404/" /><meta name="citation_keywords" content="Solute carrier family 2, facilitated glucose transporter member 10" /><meta name="citation_keywords" content="SLC2A10" /><meta name="citation_keywords" content="Arterial Tortuosity Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Arterial Tortuosity Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Bert Callewaert" /><meta name="DC.Contributor" content="Anne De Paepe" /><meta name="DC.Contributor" content="Paul Coucke" /><meta name="DC.Date" content="2014/11/13" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK253404/" /><meta name="description" content="Arterial tortuosity syndrome (ATS) is characterized by the following:" /><meta name="og:title" content="Arterial Tortuosity Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Arterial tortuosity syndrome (ATS) is characterized by the following:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK253404/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/arterial-t/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK253404/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8802A3E04150510000000001DC00BD.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK253404_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK253404_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/arvd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/arts/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK253404_"><span class="title" itemprop="name">Arterial Tortuosity Syndrome</span></h1><p class="contrib-group"><span itemprop="author">Bert Callewaert</span>, MD, PhD, <span itemprop="author">Anne De Paepe</span>, MD, PhD, and <span itemprop="author">Paul Coucke</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK253404_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK253404_ai__"><div class="contrib half_rhythm"><span itemprop="author">Bert Callewaert</span>, MD, PhD<div class="affiliation small">Center for Medical Genetics<br />Pediatrics Department<br />Ghent University Hospital<br />Ghent, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.tnegu@treawellac.treb" class="oemail">eb.tnegu@treawellac.treb</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Anne De Paepe</span>, MD, PhD<div class="affiliation small">Center for Medical Genetics<br />Ghent University Hospital<br />Ghent, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.tnegu@epeaped.enna" class="oemail">eb.tnegu@epeaped.enna</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Paul Coucke</span>, MD, PhD<div class="affiliation small">Center for Medical Genetics<br />Ghent University Hospital<br />Ghent, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.tnegu@ekcuoc.luap" class="oemail">eb.tnegu@ekcuoc.luap</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 13, 2014</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="arterial-t.Summary" itemprop="description"><h2 id="_arterial-t_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Arterial tortuosity syndrome (ATS) is characterized by the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Severe and widespread arterial tortuosity of the aorta and middle-sized arteries (with an increased risk of aneurysms and dissections) and focal and widespread stenosis which can involve the aorta and/or pulmonary arteries</div><div class="half_rhythm">The risk for ischemic vascular events involving cerebrovascular circulation and the abdominal arteries is increased. In addition, large veins may be dilated and valvular regurgitation and mitral valve prolapse can occur.</div></li><li class="half_rhythm"><div class="half_rhythm">Craniofacial involvement with characteristic facies and high palate with dental crowding</div></li><li class="half_rhythm"><div class="half_rhythm">Soft/doughy skin and other evidence of a generalized connective tissue disorder including skeletal findings (scoliosis, pectus excavatum/carinatum, joint laxity, knee/elbow contractures, arachnodactyly, camptodactyly); inguinal/abdominal wall hernia; sliding hiatal or diaphragmatic hernia; hypotonia; and ocular involvement (myopia, keratoconus)</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of ATS is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with generalized arterial tortuosity and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> (<a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a>) pathogenic variants in <i>SLC2A10</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Individuals with ATS benefit from a coordinated approach of multidisciplinary specialists in a medical center familiar with ATS or similar conditions. Although hemodynamic stress on arterial walls can be reduced with use of beta-adrenergic blockers or other medications including angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor 1 (ATIIR1) antagonists such as losartan, the efficacy of these treatments has not been established in ATS and caution is warranted when using blood pressure-lowering medications in the presence of arterial stenosis (anatomic or functional due to severe tortuosity), especially renal artery stenosis. Aneurysms and focal stenoses are amenable to surgical intervention. Skeletal manifestations such as scoliosis require management by an orthopedist, and ocular manifestations require management when possible by an ophthalmologist with expertise in connective tissue disorders. Wound healing may be delayed following surgery; thus, stitches should be placed without traction and remain in place ~10 days. A supporting mesh can be used in the surgical repair of hernias to reduce <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>.</p><p><i>Surveillance:</i> Regular cardiovascular follow up (with MRA or CT scan with 3D reconstruction from head to pelvis) starting at birth or at the time of diagnosis. Routine follow-up for: pulmonary manifestations, refractive errors and keratoconus; orthopedic complications, such as scoliosis, especially during periods of rapid growth; possible dental crowding secondary to palatal abnormalities.</p><p><i>Agents/circumstances to avoid:</i> Contact sports, competitive sports, and isometric exercise; scuba diving; agents that stimulate the cardiovascular system (including routine use of decongestants); tobacco use; sun tanning.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to evaluate the older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with ATS in order to identify as early as possible those who would benefit from treatment and surveillance for complications.</p><p><i>Pregnancy management:</i> Data on the management of women with arterial tortuosity syndrome during pregnancy and delivery are limited. Preconception counseling should include possible pregnancy-associated risks to the mother (mainly aortic root dilatation and dissection) and recommendation to discontinue medications with possible teratogenic effects (e.g., angiotensin-converting enzyme inhibitors [ACE-I], angiotensin II receptor 1 antagonists [ATIIR1] such as losartan, and anticoagulant therapy) and to begin therapy with &#x003b2;-blockers.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ATS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the <i>SLC2A10</i> pathogenic variants in the family are known<i>.</i></p></div></div><div id="arterial-t.Diagnosis"><h2 id="_arterial-t_Diagnosis_">Diagnosis</h2><p>No formal diagnostic criteria have been established for arterial tortuosity syndrome (ATS).</p><div id="arterial-t.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Arterial tortuosity syndrome <b>should be suspected</b> in individuals with severe and widespread arterial tortuosity. Major clinical findings include the following:</p><p><b>Cardiovascular involvement</b></p><ul><li class="half_rhythm"><div>Severe and widespread elongation and tortuosity of the aorta and middle-sized arteries with a propensity to form aortic and arterial aneurysms [<a class="bk_pop" href="#arterial-t.REF.pletcher.1996.121">Pletcher et al 1996</a>, <a class="bk_pop" href="#arterial-t.REF.wessels.2004.134">Wessels et al 2004</a>, <a class="bk_pop" href="#arterial-t.REF.zaidi.2005.183">Zaidi et al 2005</a>, <a class="bk_pop" href="#arterial-t.REF.drera.2007b.216">Drera et al 2007b</a>, <a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>, <a class="bk_pop" href="#arterial-t.REF.faiyazulhaque.2008.189">Faiyaz-Ul-Haque et al 2008</a>, <a class="bk_pop" href="#arterial-t.REF.allen.2009.494">Allen et al 2009</a>, <a class="bk_pop" href="#arterial-t.REF.faiyazulhaque.2009.466">Faiyaz-Ul-Haque et al 2009</a>, <a class="bk_pop" href="#arterial-t.REF.ritelli.2009.20">Ritelli et al 2009</a>, <a class="bk_pop" href="#arterial-t.REF.zaidi.2009b.867">Zaidi et al 2009b</a>, <a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>].</div></li><li class="half_rhythm"><div>Arterial dissections and stroke in some cases</div></li><li class="half_rhythm"><div>Focal stenosis of the aorta and large stenotic stretches in some cases [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>]</div></li><li class="half_rhythm"><div>Stenosis of the main and peripheral pulmonary arteries which may lead to pulmonary hypertension [<a class="bk_pop" href="#arterial-t.REF.wessels.2004.134">Wessels et al 2004</a>, <a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>]</div></li><li class="half_rhythm"><div>Large-vein dilation [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>] or in some cases tortuosity [<a class="bk_pop" href="#arterial-t.REF.moceri.2013.783">Moceri et al 2013</a>]</div></li><li class="half_rhythm"><div>Valvular regurgitation and mitral valve prolapse [<a class="bk_pop" href="#arterial-t.REF.drera.2007b.216">Drera et al 2007b</a>, <a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>, <a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>]</div></li></ul><p><b>Craniofacial involvement.</b> Characteristic features are often present and become more prominent with aging (see <a class="figpopup" href="/books/NBK253404/figure/arterial-t.F1/?report=objectonly" target="object" rid-figpopup="figarterialtF1" rid-ob="figobarterialtF1">Figure 1</a>) [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>]:</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figarterialtF1" co-legend-rid="figlgndarterialtF1"><a href="/books/NBK253404/figure/arterial-t.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figarterialtF1" rid-ob="figobarterialtF1"><img class="small-thumb" src="/books/NBK253404/bin/arterial-t-Image001.gif" src-large="/books/NBK253404/bin/arterial-t-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndarterialtF1"><h4 id="arterial-t.F1"><a href="/books/NBK253404/figure/arterial-t.F1/?report=objectonly" target="object" rid-ob="figobarterialtF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Craniofacial findings in ATS A:VI-2, male age 12 years</p></div></div><ul><li class="half_rhythm"><div>Blepharophimosis or periorbital fullness</div></li><li class="half_rhythm"><div>Downslanted palpebral fissures</div></li><li class="half_rhythm"><div>Convex nasal ridge</div></li><li class="half_rhythm"><div>Midface retrusion</div></li><li class="half_rhythm"><div>Micrognathia</div></li><li class="half_rhythm"><div>Large ears</div></li><li class="half_rhythm"><div>Long face</div></li><li class="half_rhythm"><div>High palate and dental crowding</div></li></ul><p><b>Skin</b></p><ul><li class="half_rhythm"><div>The skin is soft or doughy and is often hyperextensible. Upon stretching, the skin often shows normal recoil.</div></li><li class="half_rhythm"><div>There may be loose skin folds and redundancy as seen in cutis laxa syndromes (see <a href="#arterial-t.Differential_Diagnosis">Differential Diagnosis</a>) [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>].</div></li><li class="half_rhythm"><div>Scarring is usually normal, but may occasionally be delayed resulting in atrophic scars, especially after surgery [<a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>].</div></li></ul><p><b>Other evidence of a generalized connective tissue disorder</b> includes skeletal manifestations (scoliosis, pectus excavatum/carinatum, joint laxity, knee/elbow contractures, arachnodactyly, camptodactyly); inguinal and abdominal wall hernias; sliding hiatal or diaphragmatic hernia; hypotonia; myopia; and/or keratoconus [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>]. Joint pain may occur with aging [<a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>]. Pelvic organ prolapse can occur [<a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>].</p></div><div id="arterial-t.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of arterial tortuosity syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with generalized arterial tortuosity and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> (<a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> or <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a>) pathogenic variants in <i>SLC2A10</i>.</p><p>It is appropriate to perform molecular analysis of <i>SLC2A10</i> in an individual with the following:</p><ul><li class="half_rhythm"><div>An elongated aortic arch or arterial tortuosity on vascular imaging (echocardiography, angiography, angio-CT or angio-MRI)</div></li><li class="half_rhythm"><div>A variable combination of craniofacial characteristics (long face, periorbital fullness, convex nasal ridge); soft, hyperextensible skin, cutis laxa; suggestive skeletal manifestations (joint laxity, arachnodactyly, scoliosis, pectus deformity)</div></li><li class="half_rhythm"><div>A family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> inheritance</div></li></ul><p><b>One approach to genetic testing</b> is <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>SLC2A10,</i> the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which pathogenic variants are known to cause ATS. Sequence analysis of <i>SLC2A10</i> is performed first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> should be performed.</p><p><b>An alternate approach to genetic testing</b> is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>SLC2A10</i> and other genes of interest (see <a href="#arterial-t.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="arterial-t.T.summary_of_molecular_geneti" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Arterial Tortuosity Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK253404/table/arterial-t.T.summary_of_molecular_geneti/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arterial-t.T.summary_of_molecular_geneti_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC2A10</i></td><td headers="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup></td><td headers="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">25/29&#x000a0;<sup>3</sup></td></tr><tr><td headers="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>4</sup></td><td headers="hd_h_arterial-t.T.summary_of_molecular_geneti_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">2/29&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="arterial-t.TF.1.1"><p class="no_margin">See <a href="/books/NBK253404/#arterial-t.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#arterial-t.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants.</p></div></dd><dt>2. </dt><dd><div id="arterial-t.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="arterial-t.TF.1.3"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.coucke.2006.452">Coucke et al [2006]</a>, <a class="bk_pop" href="#arterial-t.REF.bottio.2007.252">Bottio et al [2007]</a>, <a class="bk_pop" href="#arterial-t.REF.drera.2007b.216">Drera et al [2007b]</a>, <a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al [2008]</a>, <a class="bk_pop" href="#arterial-t.REF.faiyazulhaque.2008.189">Faiyaz-Ul-Haque et al [2008]</a>, <a class="bk_pop" href="#arterial-t.REF.allen.2009.494">Allen et al [2009]</a>, <a class="bk_pop" href="#arterial-t.REF.faiyazulhaque.2009.466">Faiyaz-Ul-Haque et al [2009]</a>, <a class="bk_pop" href="#arterial-t.REF.ritelli.2009.20">Ritelli et al [2009]</a>, <a class="bk_pop" href="#arterial-t.REF.zaidi.2009b.867">Zaidi et al [2009b]</a>, <a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al [2012]</a>, <a class="bk_pop" href="#arterial-t.REF.moceri.2013.783">Moceri et al [2013]</a>, <a class="bk_pop" href="#arterial-t.REF.takahashi.2013.856">Takahashi et al [2013]</a>. Note: <a class="bk_pop" href="#arterial-t.REF.faiyazulhaque.2008.189">Faiyaz-Ul-Haque et al [2008]</a> reported the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in ten related family members from Qatar. For clarity and in order not to bias the numbers of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> families, the authors consider these ten families to be related to a single <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p></div></dd><dt>4. </dt><dd><div id="arterial-t.TF.1.4"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Included in the variety of methods that may be used are: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>5. </dt><dd><div id="arterial-t.TF.1.5"><p class="no_margin">Two probands were found to harbor a <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 of <i>SLC2A10</i> (<a class="figpopup" href="/books/NBK253404/table/arterial-t.T.slc2a10_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figarterialtTslc2a10pathogenicvariants" rid-ob="figobarterialtTslc2a10pathogenicvariants">c.1411+480_1547+299del</a>) [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>]</p></div></dd></dl></div></div></div></div></div><div id="arterial-t.Clinical_Characteristics"><h2 id="_arterial-t_Clinical_Characteristics_">Clinical Characteristics</h2><div id="arterial-t.Clinical_Description"><h3>Clinical Description</h3><p>Arterial tortuosity syndrome (ATS) is a highly variable disorder ranging from early mortality during infancy to limited manifestations in adulthood [<a class="bk_pop" href="#arterial-t.REF.pletcher.1996.121">Pletcher et al 1996</a>, <a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>, <a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>].</p><p><b>Presenting findings.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are identified in early childhood, often because of a cardiac murmur or cyanosis. Subsequently manifestations of a generalized connective tissue disorder are often observed, often prompting an echocardiogram that reveals aortic abnormalities.</p><p>More rarely, pulsatile carotid arteries or sudden arterial dissections are the initial presenting symptom.</p><p>Few reports mention cardiorespiratory failure as the initial presentation during infancy or young childhood.</p><p>Rare patients have been identified initially in adulthood, with joint aches and premature aging as the main presenting features.</p><p><b>Cardiovascular involvement.</b> The cardiovascular system is the major source of morbidity and mortality. Cardiovascular manifestations include <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> widespread tortuosity of the large and middle-sized arteries. There is increased risk at any age for aneurysm formation and dissection both at the aortic root and throughout the arterial tree [<a class="bk_pop" href="#arterial-t.REF.pletcher.1996.121">Pletcher et al 1996</a>, <a class="bk_pop" href="#arterial-t.REF.wessels.2004.134">Wessels et al 2004</a>, <a class="bk_pop" href="#arterial-t.REF.drera.a">Drera et al 2007a</a>, <a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>, <a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>]. Arterial aneurysms and dissections are amenable to surgery [<a class="bk_pop" href="#arterial-t.REF.bottio.2007.252">Bottio et al 2007</a>] (see <a href="#arterial-t.Management">Management</a>).</p><p>The risk is also increased at any age for ischemic vascular events involving cerebrovascular circulation (resulting in non-hemorrhagic stroke) and the abdominal arteries (resulting in infarctions of abdominal organs). Although arterial dissections have been reported, it is unclear if thrombosis due to endothelial damage caused by increased shear stress on the wall of the tortuous arteries may have precipitated some of these ischemic events.</p><p>Focal stenoses of the aorta and aortic branches are <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> and amenable to treatment (see <a href="#arterial-t.Management">Management</a>). In addition, long stenotic stretches of the aorta may occur.</p><p>Hypertension and ventricular hypertrophy have been reported in older individuals.</p><p>Pulmonary artery stenosis may result in pulmonary hypertension.</p><p>Although the causal relation remains to be established, a higher rate of Raynaud phenomenon and orthostatic hypotension is reported [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>].</p><p>Although early reports mentioned 40% mortality before age four years [<a class="bk_pop" href="#arterial-t.REF.wessels.2004.134">Wessels et al 2004</a>], larger series of individuals with a molecularly confirmed diagnosis indicate a milder disease spectrum [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>]. It is likely that individuals in whom the diagnosis was not molecularly confirmed had a similar disorder with a poorer prognosis &#x02013; including <a href="/books/n/gene/efemp2-cutis-laxa/"><i>EFEMP2</i>-related cutis laxa</a> (see <a href="#arterial-t.Differential_Diagnosis">Differential Diagnosis</a>). The earlier literature may also have been biased toward reporting the more severe end of the phenotypic spectrum.</p><p><b>Craniofacial involvement</b>. Typical facial characteristics (see <a href="#arterial-t.Diagnosis">Diagnosis</a>) can be present from early childhood, but usually become more prominent in older children and adults.</p><p><b>Skeletal.</b> Growth of the long bones may be excessive. Although clear dolichostenomelia (disproportionately long arms and legs compared to the trunk) is rarely present, overgrowth of the ribs may result in pectus deformity, and the hands often show arachnodactyly. Scoliosis is rare (3/15) and ranges from mild to severe; it can be progressive, mostly during periods of fast growth. <i>Pes planus</i> with hindfoot valgus may be present.</p><p>Osteopenia has been observed in rare cases [unpublished data].</p><p><b>Generalized connective tissue disorder.</b> Patients often present with joint hypermobility and are at risk for sprains and luxations. Adults are at increased risk for joint pain and fatigue [<a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>].</p><p>Affected women are more prone to prolapse of the bladder, uterus, and rectum, especially following childbirth [<a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>].</p><p>Diaphragmatic hernia and sliding hiatal hernias are reported in up to 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>, <a class="bk_pop" href="#arterial-t.REF.zaidi.2009a.588">Zaidi et al 2009a</a>].</p><p><b>Respiratory involvement.</b> Severe early-onset emphysema has been reported following an episode of bronchiolitis in one <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> <a class="def" href="/books/n/gene/glossary/def-item/compound-heterozygous/">compound heterozygous</a> for the <i>SLC2A10</i> pathogenic variants c.417T&#x0003e;A and c.692G&#x0003e;A [<a class="bk_pop" href="#arterial-t.REF.takahashi.2013.856">Takahashi et al 2013</a>].</p><p><b>Eye</b>. Keratoconus has been reported in three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, one of whom also had keratoglobus, deep corneal opacification, and diffuse corneal thinning [<a class="bk_pop" href="#arterial-t.REF.hasler.2011.345">Hasler et al 2011</a>]. Ectopia lentis has not been described. It is unclear whether myopia and astigmatism occur more frequently than in the general population.</p></div><div id="arterial-t.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>No clinically significant <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have emerged.</p></div><div id="arterial-t.Nomenclature"><h3>Nomenclature</h3><p><a class="bk_pop" href="#arterial-t.REF.lees.1969.1031">Lees et al [1969]</a> were likely the first to report the syndrome which they called "Ehlers-Danlos syndrome with multiple pulmonary artery stenoses and tortuous systemic arteries." Following this initial description, the disorder has always been considered distinct from Ehlers-Danlos syndrome, and the designation "arterial tortuosity syndrome" has been used consistently. Molecular genetic testing has not yet been performed in the individual published by <a class="bk_pop" href="#arterial-t.REF.lees.1969.1031">Lees et al [1969]</a>.</p></div><div id="arterial-t.Prevalence"><h3>Prevalence</h3><p>No reliable estimates of prevalence exist. Arterial tortuosity syndrome (ATS) is considered rare (&#x0003c;1:1000 000 live births). However, some authors suggest that it maybe more frequent than estimated [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>].</p><p>ATS occurs in all populations, but most reported cases to date are from Europe and the Middle East.</p></div></div><div id="arterial-t.Genetically_Related_Allelic_D"><h2 id="_arterial-t_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SLC2A10</i>.</p><p>Some groups have suggested <i>SLC2A10</i> as a candidate <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> for non-insulin dependent diabetes mellitus, as it lies within the 20q12-13 region linked to type 2 diabetes mellitus [<a class="bk_pop" href="#arterial-t.REF.andersen.2003.2445">Andersen et al 2003</a>, <a class="bk_pop" href="#arterial-t.REF.bento.2005.42">Bento et al 2005</a>, <a class="bk_pop" href="#arterial-t.REF.mohlke.2005.323">Mohlke et al 2005</a>, <a class="bk_pop" href="#arterial-t.REF.lin.2006.1214">Lin et al 2006</a>]. However, this remains unconfirmed [<a class="bk_pop" href="#arterial-t.REF.tang.2013.e70301">Tang et al 2013</a>] and neither individuals with ATS nor heterozygotes for a <i>SLC2A10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> show increased susceptibility for type 2 diabetes mellitus [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>].</p></div><div id="arterial-t.Differential_Diagnosis"><h2 id="_arterial-t_Differential_Diagnosis_">Differential Diagnosis</h2><p>The following disorders should be considered in the differential diagnosis of arterial tortuosity syndrome (ATS).</p><p><a href="/books/n/gene/efemp2-cutis-laxa/"><b><i>EFEMP2</i>-related cutis laxa</b></a>
<b>(<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cutis laxa type 1B [ARCL1B])</b> is characterized by cutis laxa and systemic involvement, most commonly arterial tortuosity, aneurysms and stenosis; retrognathia; joint laxity; and arachnodactyly. Severity ranges from perinatal lethality as a result of cardiopulmonary failure to manifestations limited to the vascular and craniofacial systems. Differentiation of ATS from <i>EFEMP2</i>-related cutis laxa is difficult as both skin and arterial findings overlap; however:</p><ul><li class="half_rhythm"><div>Focal stenosis at the aortic isthmus is more common in <i>EFEMP2</i>-related cutis laxa than in ATS [<a class="bk_pop" href="#arterial-t.REF.hucthagowder.2006.1075">Hucthagowder et al 2006</a>, <a class="bk_pop" href="#arterial-t.REF.renard.2010.895">Renard et al 2010</a>];</div></li><li class="half_rhythm"><div><i>EFEMP2</i>-related cutis laxa often presents with a more aggressive arterial <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> with fast progression to aneurysms; AND</div></li><li class="half_rhythm"><div>The typical facial characteristics found in ATS (including blepharophimosis, a convex nasal ridge, and a long face) are often absent in <i>EFEMP2</i>-related cutis laxa.</div></li></ul><p><a href="/books/n/gene/loeys-dietz/"><b>Loeys-Dietz syndrome</b></a>
<b>(LDS)</b> is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections) and skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus).</p><ul><li class="half_rhythm"><div>Approximately 75% of individuals with LDS type I have craniofacial manifestations (widely spaced eyes, cleft uvula/palate, craniosynostosis), findings not usually not seen in individuals with ATS.</div></li><li class="half_rhythm"><div>Arterial tortuosity is often present in LDS, but to a lesser degree than in ATS.</div></li><li class="half_rhythm"><div>Individuals with LDS present more frequently with an aneurysm of the aortic root than individuals with ATS.</div></li></ul><p>Heterozygous pathogenic variants in <i>TGFBR1</i>, <i>TGFBR2</i>, <i>SMAD3</i>, and <i>TGFB2</i> have been associated with Loeys-Dietz syndrome [<a class="bk_pop" href="#arterial-t.REF.loeys.2006.788">Loeys et al 2006</a>, <a class="bk_pop" href="#arterial-t.REF.van_de_laar.2011.121">van de Laar et al 2011</a>, <a class="bk_pop" href="#arterial-t.REF.lindsay.2012.922">Lindsay et al 2012</a>]. LDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p><a href="/books/n/gene/fbln5-cutis-laxa/"><b><i>FBLN5</i>-related cutis laxa</b></a> and <a href="/books/n/gene/ltbp4-cutis-laxa/"><b><i>LTBP4</i></b>-<b>related cutis laxa</b></a> (<b><a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cutis laxa type IA</b> and <b>type IC</b>) are two closely related entities characterized by cutis laxa, early childhood-onset pulmonary emphysema, peripheral pulmonary artery stenosis, and other evidence of a generalized connective disorder such as inguinal hernias and hollow viscus diverticula (e.g., intestine, bladder). Occasionally, supravalvular aortic stenosis is observed. Pulmonary emphysema or gastrointestinal ruptures are often the cause of death. Individuals with <i>FBLN5</i>- and <i>LTBP4</i>-related cutis laxa do not have the arterial tortuosity seen in individuals with ATS [<a class="bk_pop" href="#arterial-t.REF.callewaert.2013.111">Callewaert et al 2013</a>].</p><p><a href="/books/n/gene/menkes/"><b>Occipital horn syndrome</b></a>
<b>(OHS, <i>ATP7A</i>-related related cutis laxa)</b> is characterized by "occipital horns," distinctive wedge-shaped calcifications at the sites of attachment of the trapezius muscle and the sternocleidomastoid muscle to the occipital bone. Occipital horns may be clinically palpable or observed on skull radiographs. Individuals with OHS also have lax skin and joints, bladder diverticula, inguinal hernias, and vascular tortuosity, mainly of the cerebral vasculature. Intellect is normal or slightly reduced. The skeletal and urogenital features of OHS are distinctive. Caused by a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ATP7A</i>, OHS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p><p><b>Ehlers-Danlos syndrome</b>
<b>(EDS).</b> Individuals with EDS present with generalized joint hypermobility, variable skin and internal organ manifestations.</p><ul><li class="half_rhythm"><div class="half_rhythm">In <a href="/books/n/gene/eds3/">EDS, hypermobility type</a> (EDS type III) generalized joint hypermobility results in repetitive joint luxations and chronic musculoskeletal pain. These manifestations occur with soft and hyperextensible skin, and autonomic dysfunction, but not arterial tortuosity. Two reports mention arterial tortuosity syndrome in patients previously misdiagnosed with EDS hypermobility type, one of whom was <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <i>SLC2A10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> c.1411+1G&#x0003e;A [<a class="bk_pop" href="#arterial-t.REF.allen.2009.494">Allen et al 2009</a>] and one of whom was homozygous for the <i>SLC2A10</i> pathogenic variant c.685C&#x0003e;T [<a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>].</div><div class="half_rhythm">Haploinsufficiency of tenascin-X (encoded by <i>TNXB</i>) has been associated with EDS, hypermobility type in a small subset of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><a href="/books/n/gene/eds4/">Ehlers-Danlos syndrome, vascular type</a> (EDS type IV) is characterized by thin, translucent skin; atrophic scars, easy bruising; characteristic facial appearance (in some individuals); and arterial, intestinal, and/or uterine fragility. Vascular dissection or rupture, gastrointestinal perforation, or organ rupture are the presenting signs in the majority of adults identified to have EDS type IV. However, arterial tortuosity is absent in individuals with EDS type IV and the skin and craniofacial features are usually distinctive.</div><div class="half_rhythm">Heterozygous pathogenic variants in <i>COL3A1</i> are associated with EDS type IV. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</div></li></ul></div><div id="arterial-t.Management"><h2 id="_arterial-t_Management_">Management</h2><div id="arterial-t.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with arterial tortuosity syndrome (ATS), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Echocardiography. Aortic root measurements must be interpreted based on consideration of normal values for age and body size [<a class="bk_pop" href="#arterial-t.REF.roman.1989.507">Roman et al 1989</a>].</div></li><li class="half_rhythm"><div>MRA or CT scan with 3D reconstruction from head to pelvis to evaluate arterial tortuosity and identify arterial aneurysms and/or stenoses throughout the arterial tree</div></li><li class="half_rhythm"><div>Lung function test and imaging (radiographs, CT-scan) when emphysema is suspected</div></li><li class="half_rhythm"><div>Skeletal radiographs depending on the clinical findings (e.g., scoliosis).</div></li><li class="half_rhythm"><div>Consideration of bone densitometry based on patient history (fractures), sex, habits (smoking, alcohol consumption, sedentary life style) and age</div></li><li class="half_rhythm"><div>Evaluation of the palate to identify patients with a highly arched palate, bifid uvula, or cleft palate who may be at risk for orthodontic complications including dental crowding (see <a href="#arterial-t.Surveillance">Surveillance</a>). Patients with bifid uvula and cleft palate may be at risk for feeding difficulties.</div></li><li class="half_rhythm"><div>Eye examination by an ophthalmologist with expertise in connective tissue disorders that includes: refraction and correction of refractive errors, especially in young children at risk for amblyopia; specific assessment for keratoconus, keratoglobus, and corneal thinning</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="arterial-t.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Individuals with ATS benefit from a coordinated approach of multidisciplinary specialists including a clinical geneticist, cardiologist, ophthalmologist, orthopedist, and cardiothoracic surgeon. If feasible, individuals with ATS should be managed in a medical center familiar with this condition.</p><p><b>Cardiovascular.</b> In managing the cardiovascular features of ATS the following should be kept in mind:</p><ul><li class="half_rhythm"><div>Clinical history studies are limited.</div></li><li class="half_rhythm"><div>Vascular disease is widespread and requires repeated imaging of the complete arterial tree from head to pelvis by MRA or CTA.</div></li><li class="half_rhythm"><div>It is currently not known whether arterial dissections or thrombosis is the main cause of ischemic events.</div></li></ul><p>As is common practice in the treatment of <a href="/books/n/gene/marfan/">Marfan syndrome</a> and <a href="/books/n/gene/loeys-dietz/">Loeys-Dietz syndrome</a>, hemodynamic stress on the arterial wall can be reduced through use of beta-adrenergic blockers or other medications including angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin II receptor 1 (ATIIR1) antagonists such as losartan, when titrated to effect. While ATIIR1 antagonists may have an additional beneficial effect by attenuating TGF&#x003b2; signaling in the arterial wall, the role of TGF&#x003b2; signaling in ATS is unclear (see <a href="#arterial-t.Molecular_Genetic_Pathogenesi">Molecular Genetic Pathogenesis</a>). Importantly, the efficacy of these treatments has not been established in ATS and caution is warranted when using blood pressure-lowering medications in the presence of arterial stenosis (anatomic or functional due to severe tortuosity) &#x02013; especially renal artery stenosis, as these medications may confer a risk for renal failure.</p><p>Aneurysms and focal stenoses are amenable to surgical intervention.</p><ul><li class="half_rhythm"><div>For aortic root aneurysms, a valve-sparing procedure that precludes the need for chronic anticoagulation can be used. No data are available on the aortic diameter at which intervention is appropriate; thus, decision making should also include assessment of the family history or the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's personal assessment of risk versus benefit.</div></li><li class="half_rhythm"><div>For focal stenoses of the aorta and aortic branches, surgery, catheterization, or a hybrid of the two (transcatheter-surgical procedure) may be used [<a class="bk_pop" href="#arterial-t.REF.santoro.2008.1682">Santoro et al 2008</a>, <a class="bk_pop" href="#arterial-t.REF.vicchio.2008.736">Vicchio et al 2008</a>].</div></li></ul><p>Pulmonary artery stenosis resulting in pulmonary hypertension may be treated by catheterization and/or surgery.</p><p><b>Skeletal.</b> Bone overgrowth and ligamentous laxity can lead to severe problems (including progressive scoliosis) and should be managed by an orthopedist. Surgical stabilization of the spine may be required.</p><p>At the patient's discretion, orthotics may be used for severe <i>pes planus</i>.</p><p>Pectus excavatum can be severe; rarely, surgical intervention is medically (rather than cosmetically) indicated.</p><p><b>Eye.</b> The ocular manifestations of ATS should be managed by an ophthalmologist with expertise in connective tissue disorders. Careful and aggressive refraction and visual correction is essential, and evaluation of keratoconus is necessary.</p><p><b>Other</b></p><ul><li class="half_rhythm"><div>Hernias may recur after surgical repair. A supporting mesh can be used in the surgical repair to minimize <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>.</div></li><li class="half_rhythm"><div>Careful postoperative evaluation of (surgical) wounds is necessary as wound healing may be delayed. Note that stitches should avoid traction and should remain in place for approximately ten days.</div></li><li class="half_rhythm"><div>Emphysema is treated symptomatically. Of note, positive pressure ventilation may cause emphysematous changes to progress.</div></li><li class="half_rhythm"><div>Individuals with ATS can and should remain active with aerobic activities (e.g., swimming) performed in moderation.</div></li></ul></div><div id="arterial-t.Surveillance"><h3>Surveillance</h3><p>The following are appropriate:</p><ul><li class="half_rhythm"><div class="half_rhythm">Regular cardiovascular follow up with echocardiography, and MRI- angiography or CT scan with 3D reconstructions from head to pelvis starting at birth or at the time of diagnosis, and repeated at regular intervals depending on the initial findings and the disease course. Under stable conditions (in the absence of aneurysms, stenosis, or dilatation of the aortic root), echocardiography could be performed on a yearly basis and MRI angiography or CT scan at least every three years in older children and adults.</div><div class="half_rhythm">Pulmonary hypertension may develop secondary to pulmonary artery stenosis, requiring regular echocardiographic follow-up.</div></li><li class="half_rhythm"><div class="half_rhythm">Pulmonary follow up. Increased vigilance for emphysema is appropriate</div></li><li class="half_rhythm"><div class="half_rhythm">Routine follow-up for refractive errors and keratoconus, when possible with an ophthalmologist with expertise in connective tissue disorders</div></li><li class="half_rhythm"><div class="half_rhythm">Evaluation for orthopedic complications especially during periods of rapid growth (first two years of life and during puberty), e.g., serial radiographs to evaluate for progression of scoliosis</div></li><li class="half_rhythm"><div class="half_rhythm">Orthodontic follow-up, especially during eruption of permanent dentition because of the increased risk of dental crowding secondary to palatal abnormalities</div></li></ul></div><div id="arterial-t.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Avoid the following:</p><ul><li class="half_rhythm"><div>Contact sports, competitive sports, and isometric exercise</div></li><li class="half_rhythm"><div>Scuba diving because of pressure differences and the need for positive pressure ventilation</div></li><li class="half_rhythm"><div>Agents that stimulate the cardiovascular system including routine use of decongestants</div></li><li class="half_rhythm"><div>Use of tobacco, which increases cardiovascular risk and the likelihood of premature skin aging</div></li><li class="half_rhythm"><div>Sun tanning, which increases the likelihood of premature skin aging</div></li></ul></div><div id="arterial-t.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate the older and younger sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with ATS in order to identify as early as possible those who would benefit from institution of surveillance and preventive measures.</p><ul><li class="half_rhythm"><div>If the <i>SLC2A10</i> pathogenic variants in the family are known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify the genetic status of at-risk sibs.</div></li><li class="half_rhythm"><div>If the pathogenic variants in the family are not known, at-risk sibs should be evaluated for signs of the disorder (clinically and with echocardiography or more elaborative vascular imaging, as clinical symptoms may be very subtle) to clarify their genetic status.</div></li></ul><p>See <a href="#arterial-t.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="arterial-t.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Data on the management of women with arterial tortuosity syndrome during pregnancy and delivery are limited with only three pregnancies reported (in 2 women) to date. All pregnancies had a good outcome; however, one woman experienced pelvic organ prolapse following the vaginal delivery of her first child [<a class="bk_pop" href="#arterial-t.REF.castori.2012.1164">Castori et al 2012</a>]. The other woman, who delivered without complications at 34 weeks' gestation by elective cesarean section, was started on acetylsalicylic acid to prevent thromboembolic events eight days post partum [<a class="bk_pop" href="#arterial-t.REF.allen.2009.494">Allen et al 2009</a>].</p><p>Preconception counseling should include possible pregnancy-associated risks to the mother and medication-associated risks to the fetus.</p><p><b>The risks to the mother</b> are mainly those of aortic root dilatation and dissection. As is common practice in management in <a href="/books/n/gene/marfan/">Marfan syndrome</a>, elective aortic repair using a valve-sparing procedure (if possible) could be performed prior to conception when the aortic root diameter reaches 45 mm.</p><p>Currently, no data are available on a possible risk for pregnancy-associated uterine rupture (as is seen in <a href="/books/n/gene/loeys-dietz/">Loeys-Dietz syndrome</a> and <a href="/books/n/gene/eds4/">EDS, vascular type</a>). Prenatal and postnatal physiotherapy can minimize the risk for pelvic organ prolapse.</p><p>Peripartum intensive monitoring is advised. Pregnancies should be followed by a high-risk obstetrician and a cardiologist familiar with this or related conditions.</p><p>Increased surveillance of the aortic root and previously detected aneurysms during pregnancy and following delivery is recommended because of the increased risk for progressive dilatation. Echocardiography is suggested every two to three months from conception until six months post partum.</p><p>Delivery should be planned in a center with experience with this or related conditions. It is currently unclear whether caesarean section or vaginal delivery is preferable.</p><p><b>Medication-associated risks to the fetus.</b> The effects of angiotensin-converting enzyme inhibitors (ACE-I) on the fetus in the first trimester of pregnancy are incompletely understood; however, use in the second and third trimesters of pregnancy can lead to fetal death and damage. Angiotensin II receptor 1 antagonists (ATIIR1) such as losartan are thought to lead to similar fetal effects as ACE-I, including fetal damage, oligohydramnios, and fetal death, if taken during the second and/or third trimesters of pregnancy.</p><ul><li class="half_rhythm"><div>Ideally, women with ATS who are planning a pregnancy should transition to a different antihypertensive medication (e.g., a beta-blocker) prior to conception.</div></li><li class="half_rhythm"><div>Women with ATS who become pregnant while taking an ACE-I or an ATIIR1 should be transitioned to a different antihypertensive medication as soon as the pregnancy is recognized.</div></li></ul><p>Women undergoing a non-valve sparing aortic root replacement before pregnancy should be advised of the risk associated with anticoagulant therapy during pregnancy.</p></div><div id="arterial-t.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="arterial-t.Genetic_Counseling"><h2 id="_arterial-t_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="arterial-t.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Arterial tortuosity syndrome (ATS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner.</p></div><div id="arterial-t.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual are obligate heterozygotes (i.e., carriers of one <i>SLC2A10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the risk of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SLC2A10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is 2/3.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with ATS are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SLC2A10</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of an <i>SLC2A10</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div id="arterial-t.Carrier_Heterozygote_Detectio"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the pathogenic variants in the family<i>.</i></p></div><div id="arterial-t.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#arterial-t.Evaluation_of_Relatives_at_Ri">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="arterial-t.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>SLC2A10</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for ATS are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="arterial-t.Resources"><h2 id="_arterial-t_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition/arterial-tortuosity-syndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Arterial tortuosity syndrome</a></div></li><li class="half_rhythm"><div><b>American Heart Association (AHA)</b></div><div>7272 Greenville Avenue</div><div>Dallas TX 75231</div><div><b>Phone:</b> 800-242-8721 (toll-free)</div><div><b>Email:</b> review.personal.info@heart.org</div><div><a href="http://www.americanheart.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.americanheart.org</a></div></li></ul></div><div id="arterial-t.Molecular_Genetics"><h2 id="_arterial-t_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="arterial-t.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Arterial Tortuosity Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK253404/table/arterial-t.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arterial-t.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_arterial-t.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_arterial-t.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_arterial-t.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_arterial-t.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_arterial-t.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_arterial-t.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_arterial-t.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/81031" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SLC2A10</i></a></td><td headers="hd_b_arterial-t.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=81031" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">20q13<wbr style="display:inline-block"></wbr>​.12</a></td><td headers="hd_b_arterial-t.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O95528" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Solute carrier family 2, facilitated glucose transporter member 10</a></td><td headers="hd_b_arterial-t.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/SLC2A10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC2A10 database</a></td><td headers="hd_b_arterial-t.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SLC2A10" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC2A10</a></td><td headers="hd_b_arterial-t.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SLC2A10[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SLC2A10</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="arterial-t.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="arterial-t.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Arterial Tortuosity Syndrome (<a href="/omim/208050,606145" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK253404/table/arterial-t.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arterial-t.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/208050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">208050</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ARTERIAL TORTUOSITY SYNDROME; ATORS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/606145" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">606145</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER 10; SLC2A10</td></tr></tbody></table></div></div><div id="arterial-t.Molecular_Genetic_Pathogenesi"><h3>Molecular Genetic Pathogenesis</h3><p><i>SLC2A10</i> encodes GLUT10, a member of the class III facilitative glucose transporter family. The transporter is located intracellularly; however, neither the exact localization nor the transported substances have been clarified with certainty. Using immunohistochemistry, different authors have detected GLUT10 in the nuclear membrane, the mitochondria, and/or the endoplasmic reticulum [<a class="bk_pop" href="#arterial-t.REF.coucke.2006.452">Coucke et al 2006</a>, <a class="bk_pop" href="#arterial-t.REF.lee.2010.3721">Lee et al 2010</a>]. The localization may differ among different cell types or physiologic states.</p><p>In vitro studies demonstrated transport of both glucose and dehydroascorbic acid [<a class="bk_pop" href="#arterial-t.REF.dawson.2001.186">Dawson et al 2001</a>, <a class="bk_pop" href="#arterial-t.REF.lee.2010.3721">Lee et al 2010</a>]. Some authors suggest that GLUT10 transports DHA into the endoplasmic reticulum or mitochondria [<a class="bk_pop" href="#arterial-t.REF.lee.2010.3721">Lee et al 2010</a>].</p><p>Analysis of end-stage diseased arteries showed increased TGF&#x003b2; signaling, similar to that observed in related disorders including <a href="/books/n/gene/loeys-dietz/">Loeys-Dietz syndrome</a> and <a href="/books/n/gene/fbln5-cutis-laxa/"><i>FBLN4</i>-related cutis laxa</a> [<a class="bk_pop" href="#arterial-t.REF.loeys.2005.275">Loeys et al 2005</a>, <a class="bk_pop" href="#arterial-t.REF.renard.2010.895">Renard et al 2010</a>]. However, studies in a zebrafish model show reduced signaling in early developmental stages. Furthermore, mitochondrial dysfunction was shown in this model [<a class="bk_pop" href="#arterial-t.REF.willaert.2012.1248">Willaert et al 2012</a>].</p><p><b>Gene structure.</b>
<i>SLC2A10</i> comprises five exons and produces a single 4241 bp transcript, which in turn encodes a protein of 541 amino acid residues. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK253404/#arterial-t.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Most pathogenic variants are recurrent (c.243C&#x0003e;G, c.1334delG, c.685C&#x0003e;T, c.1276G&#x0003e;T, c.1411+480_1547+299del, c.394C&#x0003e;T, c.692G&#x0003e;A, and c.756C&#x0003e;A), and founder effects have been shown for some [<a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al 2008</a>].</p><div id="arterial-t.T.slc2a10_pathogenic_variants" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p><i>SLC2A10</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK253404/table/arterial-t.T.slc2a10_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__arterial-t.T.slc2a10_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.243C&#x0003e;G&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser81Arg&#x000a0;<sup>1,&#x000a0;2,&#x000a0;3</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_3" rowspan="9" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_030777.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_030777<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_110404.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_110404<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.394C&#x0003e;T&#x000a0;<sup>4</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg132Trp&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.417T&#x0003e;A&#x000a0;<sup>5</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr139Ter&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.685C&#x0003e;T&#x000a0;<sup>4,&#x000a0;6,&#x000a0;7</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg229Ter&#x000a0;<sup>4,&#x000a0;6</sup></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.692G&#x0003e;A&#x000a0;<sup>4,&#x000a0;5</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg231Gln&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.756C&#x0003e;A&#x000a0;<sup>5,&#x000a0;8</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys252Ter&#x000a0;<sup>5,&#x000a0;8</sup></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1276G&#x0003e;T&#x000a0;<sup>4</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly426Trp&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1334delG&#x000a0;<sup>1,&#x000a0;4</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly445fsTer40&#x000a0;<sup>1,&#x000a0;4</sup></td></tr><tr><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1411+480_c.1547+299del&#x000a0;<sup>4</sup></td><td headers="hd_h_arterial-t.T.slc2a10_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly471_Arg515delTerfs&#x000a0;<sup>4</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="arterial-t.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.coucke.2006.452">Coucke et al [2006]</a></p></div></dd><dt>2. </dt><dd><div id="arterial-t.TF.2.2"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.faiyazulhaque.2009.466">Faiyaz-Ul-Haque et al [2009]</a></p></div></dd><dt>3. </dt><dd><div id="arterial-t.TF.2.3"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.faiyazulhaque.2008.189">Faiyaz-Ul-Haque et al [2008]</a></p></div></dd><dt>4. </dt><dd><div id="arterial-t.TF.2.4"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.callewaert.2008.150">Callewaert et al [2008]</a></p></div></dd><dt>5. </dt><dd><div id="arterial-t.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.takahashi.2013.856">Takahashi et al [2013]</a></p></div></dd><dt>6. </dt><dd><div id="arterial-t.TF.2.6"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.ritelli.2009.20">Ritelli et al [2009]</a></p></div></dd><dt>7. </dt><dd><div id="arterial-t.TF.2.7"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.allen.2009.494">Allen et al [2009]</a></p></div></dd><dt>8. </dt><dd><div id="arterial-t.TF.2.8"><p class="no_margin"><a class="bk_pop" href="#arterial-t.REF.zaidi.2009b.867">Zaidi et al [2009b]</a></p></div></dd></dl></div></div></div><p>For additional variants, see <a href="/books/NBK253404/bin/arterial-t-Table3.pdf">Table 3</a> (pdf).</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The solute carrier family 2, facilitated glucose transporter member 10 protein consists of 541 amino acids. It is a membrane bound transporter protein with 12 transmembrane domains (TMD). It has a small hydrophilic loop with between TDM 6 and 7, and a large exofacial loop between TDM 9 and 10, containing potential N-hydroxylation sites.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Pathogenic variants lead to loss of function of the protein. About half of all currently known pathogenic variants are expected to result in absent protein due to <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>-mediated decay. Missense variants are expected to interfere with the transporter function. Most of the <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants are localized on the TMD or the endofacial site of the protein.</p></div></div><div id="arterial-t.References"><h2 id="_arterial-t_References_">References</h2><div id="arterial-t.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.allen.2009.494">Allen VM, Horne SG, Penney LS, Rapchuk IL, Brock JA, Thompson DL, Stinson DA. Successful outcome in pregnancy with arterial tortuosity syndrome. <span><span class="ref-journal">Obstet Gynecol. </span>2009;<span class="ref-vol">114</span>:494–8.</span> [<a href="/pubmed/19622975" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19622975</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.andersen.2003.2445">Andersen G, Rose CS, Hamid YH, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits. <span><span class="ref-journal">Diabetes. </span>2003;<span class="ref-vol">52</span>:2445–8.</span> [<a href="/pubmed/12941788" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12941788</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.bento.2005.42">Bento JL, Bowden DW, Mychaleckyj JC, Hirakawa S, Rich SS, Freedman BI, Segade F. Genetic analysis of the GLUT10 glucose transporter (SLC2A10) polymorphisms in Caucasian American type 2 diabetes. <span><span class="ref-journal">BMC Med Genet. </span>2005;<span class="ref-vol">6</span>:42.</span> [<a href="/pmc/articles/PMC1325051/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1325051</span></a>] [<a href="/pubmed/16336637" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16336637</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.bottio.2007.252">Bottio T, Bisleri G, Piccoli P, Muneretto C. Valve-sparing aortic root replacement in a patient with a rare connective tissue disorder: arterial tortuosity syndrome. <span><span class="ref-journal">J Thorac Cardiovasc Surg. </span>2007;<span class="ref-vol">133</span>:252–3.</span> [<a href="/pubmed/17198824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17198824</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.callewaert.2013.111">Callewaert B, Su CT, Van Damme T, Vlummens P, Malfait F, Vanakker O, Schulz B, Mac Neal M, Davis EC, Lee JG, Salhi A, Unger S, Heimdal K, De Almeida S, Kornak U, Gaspar H, Bresson JL, Prescott K, Gosendi ME, Mansour S, Pi&#x000e9;rard GE, Madan-Khetarpal S, Sciurba FC, Symoens S, Coucke PJ, Van Maldergem L, Urban Z, De Paepe A. Comprehensive clinical and molecular analysis of 12 families with type 1 recessive cutis laxa. <span><span class="ref-journal">Hum Mutat. </span>2013;<span class="ref-vol">34</span>:111–21.</span> [<a href="/pmc/articles/PMC4105850/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4105850</span></a>] [<a href="/pubmed/22829427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22829427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.callewaert.2008.150">Callewaert BL, Willaert A, Kerstjens-Frederikse WS, De Backer J, Devriendt K, Albrecht B, Ramos-Arroyo MA, Doco-Fenzy M, Hennekam RC, Pyeritz RE, Krogmann ON, Gillessen-kaesbach G, Wakeling EL, Nik-zainal S, Francannet C, Mauran P, Booth C, Barrow M, Dekens R, Loeys BL, Coucke PJ, De Paepe AM. Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families. <span><span class="ref-journal">Hum Mutat. </span>2008;<span class="ref-vol">29</span>:150–8.</span> [<a href="/pubmed/17935213" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17935213</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.castori.2012.1164">Castori M, Ritelli M, Zoppi N, Molisso L, Chiarelli N, Zaccagna F, Grammatico P, Colombi M. Adult presentation of arterial tortuosity syndrome in a 51-year-old woman with a novel homozygous c.1411+1G&#x0003e;A mutation in the SLC2A10 gene. <span><span class="ref-journal">Am J Med Genet A. </span>2012;<span class="ref-vol">158A</span>:1164–9.</span> [<a href="/pubmed/22488877" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22488877</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.coucke.2006.452">Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:452–7.</span> [<a href="/pubmed/16550171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16550171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.dawson.2001.186">Dawson PA, Mychaleckyj JC, Fossey SC, Mihic SJ, Craddock AL, Bowden DW. Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. <span><span class="ref-journal">Mol Genet Metab. </span>2001;<span class="ref-vol">74</span>:186–99.</span> [<a href="/pubmed/11592815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11592815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.drera.a">Drera B, Barlati S, Colombi M. Ischemic stroke in an adolescent with arterial tortuosity syndrome. Neurology. 2007a;68:1637. [<a href="/pubmed/17485657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17485657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.drera.2007b.216">Drera B, Guala A, Zoppi N, Gardella R, Franceschini P, Barlati S, Colombi M. Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2007b;<span class="ref-vol">143A</span>:216–8.</span> [<a href="/pubmed/17163528" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17163528</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.faiyazulhaque.2009.466">Faiyaz-Ul-Haque M, Zaidi SH, Al-Sanna N, Alswaid A, Momenah T, Kaya N, Al-Dayel F, Bouhoaigah I, Saliem M, Tsui LC, Teebi AS. A novel missense and a recurrent mutation in SLC2A10 gene of patients affected with arterial tortuosity syndrome. <span><span class="ref-journal">Atherosclerosis. </span>2009;<span class="ref-vol">203</span>:466–71.</span> [<a href="/pubmed/18774132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18774132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.faiyazulhaque.2008.189">Faiyaz-Ul-Haque M, Zaidi SH, Wahab AA, Eltohami A, Al-Mureikhi MS, Al-Thani G, Peltekova VD, Tsui LC, Teebi AS. Identification of a p.Ser81Arg encoding mutation in SLC2A10 gene of arterial tortuosity syndrome patients from 10 Qatari families. <span><span class="ref-journal">Clin Genet. </span>2008;<span class="ref-vol">74</span>:189–93.</span> [<a href="/pubmed/18565096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18565096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.hasler.2011.345">Hasler S, St&#x000fc;rmer J, Kaufmann C. Keratoglobus and deep stromal corneal opacification in a case of arterial tortuosity syndrome. <span><span class="ref-journal">Klin Monbl Augenheilkd. </span>2011;<span class="ref-vol">228</span>:345–6.</span> [<a href="/pubmed/21484644" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21484644</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.hucthagowder.2006.1075">Hucthagowder V, Sausgruber N, Kim KH, Angle B, Marmorstein LY, Urban Z. Fibulin-4: a novel gene for an autosomal recessive cutis laxa syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2006;<span class="ref-vol">78</span>:1075–80.</span> [<a href="/pmc/articles/PMC1474103/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1474103</span></a>] [<a href="/pubmed/16685658" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16685658</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.lee.2010.3721">Lee YC, Huang HY, Chang CJ, Cheng CH, Chen YT. Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome. <span><span class="ref-journal">Hum Mol Genet. </span>2010;<span class="ref-vol">19</span>:3721–33.</span> [<a href="/pubmed/20639396" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20639396</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.lees.1969.1031">Lees MH, Menashe VD, Sunderland CO, Mgan CL, Dawson PJ. Ehlers-Danlos syndrome associated with multiple pulmonary artery stenoses and tortuous systemic arteries. <span><span class="ref-journal">J Pediatr. </span>1969;<span class="ref-vol">75</span>:1031–6.</span> [<a href="/pubmed/5352829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5352829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.lin.2006.1214">Lin WH, Chuang LM, Chen CH, Yeh JI, Hsieh PS, Cheng CH, Chen YT. Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population. <span><span class="ref-journal">Diabetologia. </span>2006;<span class="ref-vol">49</span>:1214–21.</span> [<a href="/pubmed/16586067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16586067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.lindsay.2012.922">Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, Kempers MJ, Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid BM, Yang MH, Bongers EM, Timmermans J, Braverman AC, Canham N, Mortier GR, Brunner HG, Byers PH, Van Eyk J, Van Laer L, Dietz HC, Loeys BL. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:922–7.</span> [<a href="/pmc/articles/PMC3616632/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3616632</span></a>] [<a href="/pubmed/22772368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22772368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.loeys.2005.275">Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:275–81.</span> [<a href="/pubmed/15731757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15731757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.loeys.2006.788">Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">355</span>:788–98.</span> [<a href="/pubmed/16928994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16928994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.moceri.2013.783">Moceri P, Albuisson J, Saint-Faust M, Casagrande F, Giuliano F, Devos C, Benoit P, Hugues N, Ducreux D, Cerboni P, Dageville C, Jeunemaitre X. Arterial tortuosity syndrome: early diagnosis and association with venous tortuosity. <span><span class="ref-journal">J Am Coll Cardiol. </span>2013;<span class="ref-vol">61</span>:783.</span> [<a href="/pubmed/23410549" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23410549</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.mohlke.2005.323">Mohlke KL, Skol AD, Scott LJ, Valle TT, Bergman RN, Tuomilehto J, Boehnke M, Collins FS., FUSION Study Group.  Evaluation of SLC2A10 (GLUT10) as a candidate gene for type 2 diabetes and related traits in Finns. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">85</span>:323–7.</span> [<a href="/pubmed/15936967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15936967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.pletcher.1996.121">Pletcher BA, Fox JE, Boxer RA, Singh S, Blumenthal D, Cohen T, Brunson S, Tafreshi P, Kahn E. Four sibs with arterial tortuosity: description and review of the literature. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">66</span>:121–8.</span> [<a href="/pubmed/8958317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8958317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.renard.2010.895">Renard M, Holm T, Veith R, Callewaert BL, Ad&#x000e8;s LC, Baspinar O, Pickart A, Dasouki M, Hoyer J, Rauch A, Trapane P, Earing MG, Coucke PJ, Sakai LY, Dietz HC, De Paepe AM, Loeys BL. Altered TGFbeta signaling and cardiovascular manifestations in patients with autosomal recessive cutis laxa type I caused by fibulin-4 deficiency. <span><span class="ref-journal">Eur J Hum Genet. </span>2010;<span class="ref-vol">18</span>:895–901.</span> [<a href="/pmc/articles/PMC2987390/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2987390</span></a>] [<a href="/pubmed/20389311" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20389311</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.ritelli.2009.20">Ritelli M, Drera B, Vicchio M, Puppini G, Biban P, Pilati M, Prioli MA, Barlati S, Colombi M. Arterial tortuosity syndrome in two Italian paediatric patients. <span><span class="ref-journal">Orphanet J Rare Dis. </span>2009;<span class="ref-vol">4</span>:20.</span> [<a href="/pmc/articles/PMC2759904/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2759904</span></a>] [<a href="/pubmed/19781076" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19781076</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.roman.1989.507">Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. <span><span class="ref-journal">Am J Cardiol. </span>1989;<span class="ref-vol">64</span>:507–12.</span> [<a href="/pubmed/2773795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2773795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.santoro.2008.1682">Santoro G, Caianiello G, Rossi G, Farina G, Russo MG, Calabr&#x000f2; R. Hybrid transcatheter-surgical strategy in arterial tortuosity syndrome. <span><span class="ref-journal">Ann Thorac Surg. </span>2008;<span class="ref-vol">86</span>:1682–4.</span> [<a href="/pubmed/19049778" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19049778</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.takahashi.2013.856">Takahashi Y, Fujii K, Yoshida A, Morisaki H, Kohno Y, Morisaki T. Artery tortuosity syndrome exhibiting early-onset emphysema with novel compound heterozygous SLC2A10 mutations. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:856–9.</span> [<a href="/pubmed/23494979" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23494979</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.tang.2013.e70301">Tang L, Wang L, Liao Q, Wang Q, Xu L, Bu S, Huang Y, Zhang C, Ye H, Xu X, Liu Q, Ye M, Mai Y, Duan S. Genetic associations with diabetes: meta-analyses of 10 candidate polymorphisms. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e70301.</span> [<a href="/pmc/articles/PMC3726433/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3726433</span></a>] [<a href="/pubmed/23922971" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23922971</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.van_de_laar.2011.121">van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, Hoedemaekers YM, Willemsen R, Severijnen LA, Venselaar H, Vriend G, Pattynama PM, Coll&#x000e9;e M, Majoor-Krakauer D, Poldermans D, Frohn-Mulder IM, Micha D, Timmermans J, Hilhorst-Hofstee Y, Bierma-Zeinstra SM, Willems PJ, Kros JM, Oei EH, Oostra BA, Wessels MW, Bertoli-Avella AM. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:121–6.</span> [<a href="/pubmed/21217753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21217753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.vicchio.2008.736">Vicchio M, Santoro G, Carrozza M, Caianiello G. Hybrid approach in a case of arterial tortuosity syndrome. <span><span class="ref-journal">Interact Cardiovasc Thorac Surg. </span>2008;<span class="ref-vol">7</span>:736–7.</span> [<a href="/pubmed/18467428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18467428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.wessels.2004.134">Wessels MW, Catsman-Berrevoets CE, Mancini GM, Breuning MH, Hoogeboom JJ, Stroink H, Frohn-Mulder I, Coucke PJ, Paepe AD, Niermeijer MF, Willems PJ. Three new families with arterial tortuosity syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">131</span>:134–43.</span> [<a href="/pubmed/15529317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15529317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.willaert.2012.1248">Willaert A, Khatri S, Callewaert BL, Coucke PJ, Crosby SD, Lee JG, Davis EC, Shiva S, Tsang M, De Paepe A, Urban Z. GLUT10 is required for the development of the cardiovascular system and the notochord and connects mitochondrial function to TGF&#x003b2; signaling. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:1248–59.</span> [<a href="/pmc/articles/PMC3284116/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3284116</span></a>] [<a href="/pubmed/22116938" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22116938</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.zaidi.2009a.588">Zaidi SH, Meyer S, Peltekova I, Teebi AS, Faiyaz-Ul-Haque M. Congenital diaphragmatic abnormalities in arterial tortuosity syndrome patients who carry mutations in the SLC2A10 gene. <span><span class="ref-journal">Clin Genet. </span>2009a;<span class="ref-vol">75</span>:588–9.</span> [<a href="/pubmed/19508422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19508422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.zaidi.2009b.867">Zaidi SH, Meyer S, Peltekova VD, Lindinger A, Teebi AS, Faiyaz-Ul-Haque M. A novel non-sense mutation in the SLC2A10 gene of an arterial tortuosity syndrome patient of Kurdish origin. <span><span class="ref-journal">Eur J Pediatr. </span>2009b;<span class="ref-vol">168</span>:867–70.</span> [<a href="/pubmed/18818946" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18818946</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="arterial-t.REF.zaidi.2005.183">Zaidi SH, Peltekova V, Meyer S, Lindinger A, Paterson AD, Tsui LC, Faiyaz-Ul-Haque M, Teebi AS. A family exhibiting arterial tortuosity syndrome displays homozygosity for markers in the arterial tortuosity locus at chromosome 20q13. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">67</span>:183–8.</span> [<a href="/pubmed/15679832" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15679832</span></a>]</div></li></ul></div></div><div id="arterial-t.Chapter_Notes"><h2 id="_arterial-t_Chapter_Notes_">Chapter Notes</h2><div id="arterial-t.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.cmgg.be/en" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">University of Ghent Center for Medical Genetics</a></p><p>Bert Callewaert is a clinical geneticist and an investigator at the Center for Medical Genetics of the Ghent University Hospital. His main research interest focuses on connective tissue disorders including the arterial tortuosity syndrome, cutis laxa syndromes, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> contractural arachnodactyly, Ehlers-Danlos syndromes and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> thoracic aortic aneurysms.</p><p>Paul Coucke and Anne De Paepe are respectively supervisor of the connective tissue laboratory and head of the department at the Center for Medical Genetics.</p></div><div id="arterial-t.Acknowledgments"><h3>Acknowledgments</h3><p>Bert Callewaert is a senior clinical investigator of the Fund for Scientific Research-Flanders. This research is sponsored by a Methusalem grant from the Ghent University (BOF 08/01M01108)</p></div><div id="arterial-t.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>13 November 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>14 February 2014 (bc) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK253404</span><span class="label">PMID: <a href="/pubmed/25392904" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">25392904</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/arvd/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/arts/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK253404&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK253404/?report=reader">PubReader</a></li><li><a href="/books/NBK253404/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK253404" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK253404" style="display:none" title="Cite this Page"><div class="bk_tt">Callewaert B, De Paepe A, Coucke P. Arterial Tortuosity Syndrome. 2014 Nov 13. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK253404/pdf/Bookshelf_NBK253404.pdf">PDF version of this page</a> (917K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#arterial-t.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#arterial-t.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#arterial-t.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#arterial-t.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#arterial-t.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#arterial-t.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#arterial-t.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#arterial-t.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#arterial-t.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#arterial-t.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#arterial-t.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=81031[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SLC2A10</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=3306904" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3306904" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3306904" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=3306904" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301312" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Loeys-Dietz Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Loeys BL, Dietz HC. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301560" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Contractural Arachnodactyly</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Contractural Arachnodactyly<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Callewaert B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301454" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shprintzen-Goldberg Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shprintzen-Goldberg Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Greally MT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301635" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLOD1</i>-Related Kyphoscoliotic Ehlers-Danlos Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">PLOD1</i>-Related Kyphoscoliotic Ehlers-Danlos Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Yeowell HN, Steinmann B. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=25392904" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=25392904" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04192ddde089116946bcb7">Arterial Tortuosity Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Arterial Tortuosity Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:21:33-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE8802A3E04150510000000001DC00BD&amp;ncbi_session=CE8802A3E04192C1_0476SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK253404%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK253404&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK253404/&amp;ncbi_pagename=Arterial Tortuosity Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8802A3E04192C1_0476SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>